1. Home
  2. UVSP vs EVO Comparison

UVSP vs EVO Comparison

Compare UVSP & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UVSP

Univest Financial Corporation

HOLD

Current Price

$44.21

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.96

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVSP
EVO
Founded
1876
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
UVSP
EVO
Price
$44.21
$1.96
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$36.67
$7.00
AVG Volume (30 Days)
247.9K
44.2K
Earning Date
04-22-2026
04-08-2026
Dividend Yield
2.44%
N/A
EPS Growth
21.32
N/A
EPS
0.96
N/A
Revenue
$328,056,000.00
N/A
Revenue This Year
$11.65
$1.37
Revenue Next Year
$4.77
$10.05
P/E Ratio
$46.02
N/A
Revenue Growth
9.64
N/A
52 Week Low
$27.91
$1.94
52 Week High
$45.46
$4.42

Technical Indicators

Market Signals
Indicator
UVSP
EVO
Relative Strength Index (RSI) 57.95 25.35
Support Level $42.91 N/A
Resistance Level $45.41 $3.36
Average True Range (ATR) 0.85 0.10
MACD -0.13 -0.05
Stochastic Oscillator 70.35 1.02

Price Performance

Historical Comparison
UVSP
EVO

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: